AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06546566 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Breathing Exercises
Description: The conventional breathing exercises program will consist of routine breathing exercises. Breathing exercises will be given 2 times a day, 5 repetitions, 2 sets. The program will last for 8 weeks, 5 days a week, 30 minutes a day.
Study NCT06377358 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tecar Therapy
Description: Tecar Therapy at 1Mhz radiofrequency by the use of a C-400 device. The duration of the treatment will be 5 weeks, where 10 sessions will be carried out, 2 per week
Study NCT05628623 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cytarabine
Description: Arm A: CBF-Cytarabine 3000 mg/m2 or 1500 mg/m2 IV twice daily (BID), 12 hours apart x 6 doses either on Days 1, 3, and 5 OR Days 1, 2, and 3
Study NCT05628623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Arm A: CBF-Cytarabine 3000 mg/m2 or 1500 mg/m2 IV twice daily (BID), 12 hours apart x 6 doses either on Days 1, 3, and 5 OR Days 1, 2, and 3
Study NCT05628623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Venetoclax 100 mg daily Day 1 through Day 8 Venetoclax 400 mg orally once daily on Days 1-14 Venetoclax 400 mg orally once daily on Days 1-28
Study NCT05628623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CPX-351
Description: Daunorubicin 29 mg/m2/Cytarabine 65 mg/m2 liposome IV on Days 1 and 3
Study NCT05628623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine 75 mg/m2 IV/SC on Days 1-7 OR Days 1-5 and Days 8-9 (per institutional preference)
Study NCT05436821 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Auricular vagus nerve stimulation
Description: Autonomic nerve system regulation
Study NCT05112965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Pemetrexed will be administered as directed per the parent study.
Study NCT05112965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: Pemetrexed will be administered as directed per the parent study.
Study NCT05436821 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Auricular Vagus Nerve Stimulation (AVNS)
Description: Sham Auricular Vagus Nerve Stimulation (AVNS)
Study NCT05267574 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REN001
Description: Once daily dosing
Study NCT06256250 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pulpectomy treatment will be done using the adaptive xp endo shaper.
Description: the patient will be anesthetized by local anesthesia. the rubber dam will be used for isolation. caries will be removed using high speed handpiece. determination of working length using apex locator. the canal patency will be checked with a # 10 K file, and gliding path until #15 K- file. the root canals of primary molars will be cleaned and shaped in pulpectomy treatment using the adaptive xp endo shaper. it is single file technique saves time and help with patient cooperation . the endomotor will be activated at aspeed of 800 rpm and 1 Ncm torque. the canals will be irrigated using 2.5% Nacol ending with 0.9% normal saline canal irrigation. the canals will be dried with paper points and obturated with Metapex. teeth will be restored by glass ionomer restoration than stainless steel crown.
Study NCT06256250 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pulpectomy treatment will be done using FANTA AF baby files.
Description: the patient will be anesthetized by local anesthesia. the rubber dam will be used for isolation. caries will be removed using high speed handpiece. determination of working length using apex locator. The canal patency will be checked with a #10 K-file, and a glide path until #15 K-file will be created .the root canals of primary molars will be cleaned and shaped in pulpectomy treatment using FANTA AF baby files. it is pediatric rotary system consists of 4 files specialized for primary molars.Open file: #17, taper 08.~* BTF1: #20, taper 04, Yellow~* BTF2: #25, taper 04, Red~* BTF3: #30, taper 04, Blue The file will be activated at speed 350 rpm and torque 2 N until reaching the full working length. the canals will be irrigated using 2.5% Nacol ending with 0.9% normal saline canal irrigation. the canals will be dried with paper points and obturated with Metapex. teeth will be restored by glass ionomer restoration than stainless steel crown.
Study NCT05112965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel will be administered as directed per the parent study.
Study NCT05112965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: Paclitaxel will be administered as directed per the parent study.
Study NCT06256250 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pulpectomy treatment will be done using hand k files.
Description: the patient will be anesthetized by local anesthesia. the rubber dam will be used for isolation. caries will be removed using high speed handpiece. determination of working length using apex locator. the root canals of primary molars will be cleaned and shaped in pulpectomy treatment using hand k files starting with #15 stainless steel hand K file. they are manual files, they are standard for root canal treatment (control group). the canals will be irrigated using 2.5% Nacol ending with 0.9% normal saline canal irrigation. the canals will be dried with paper points and obturated with Metapex. teeth will be restored by glass ionomer restoration than stainless steel crown.
Study NCT04222998 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home visits for end line surveys
Description: Households will be revisited after 1 year of grace-period for baseline end line surveys.
Study NCT04222998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home visits for end line surveys
Description: Households will be revisited after 1 year of grace-period for baseline end line surveys.
Study NCT05112965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Description: Enzalutamide will be administered as directed per the parent study.
Study NCT05112965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enzalutamide
Description: Enzalutamide will be administered as directed per the parent study.
Study NCT06529016 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Luminopia, a virtual reality headset
Description: Subjects will be provided with the equipment to use in their homes for six hours usage per week (1 hour 6 days a week), for 12 weeks.
Study NCT06529016 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Paper pre- survey
Description: Pre-survey to be completed by the parent and child. Questions may be skipped. Survey developed by the study team
Study NCT06529016 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Paper Survey
Description: Post-survey to be completed by the parent and child. Questions may be skipped. Survey developed by the study team
Study NCT05245071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tusamitamab ravtansine
Description: Pharmaceutical Form: Concentrate for solution Route of Administration: Intravenous infusion
Study NCT04222998 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Measurement of child's height-for-age and weight-for-age
Description: The child's height-for-age and weight-for-age will be measured for participating dyads at the time of the baseline and end line surveys.
Study NCT04222998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Measurement of child's height-for-age and weight-for-age
Description: The child's height-for-age and weight-for-age will be measured for participating dyads at the time of the baseline and end line surveys.
Study NCT04861350 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: motor imagery with action observation
Description: Standing clamshell exercise with elastic band, sliding, and Romanian deadlift exercise will be instructed to the subjects with video, and they will practice each exercise for 3 times in physical to familiarize with the program. Then, the subjects will mentally simulate each exercise with video 10 times for a set, 3 sets totally. With 2 min interval between each sets, it will take approximately 8 minutes to finish each movement. It will also take 3 min for resting between each program.
Study NCT04861350 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: physical training
Description: Standing clamshell exercise with elastic band, sliding, and Romanian deadlift exercise will be instructed to the subjects with video, and they will practice each exercise for 3 times in physical to familiarize with the program. Then, the subjects will physically perform each exercise with supervision of investigator 10 times for a set, 3 sets totally. With 2 min interval between each sets, it will take approximately 8 minutes to finish each movement. It will also take 3 min for resting between each program.
Study NCT04861350 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: combine physical training and motor imagery with action observation
Description: Standing clamshell exercise with elastic band, sliding, and Romanian deadlift exercise will be instructed to the subjects with video, and they will practice each exercise for 3 times in physical to familiarize with the program. Then, each exercises will be mentally simulated with video for a set and physically performed with supervision of investigator for 2 sets, 10 times for each set and 3 sets totally. With 2 min interval between each sets, it will take approximately 8 minutes to finish each movement. It will also take 3 min for resting between each program.
Study NCT05713877 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: Study drug will be given at 21:00 daily, starting on the day of enrolment until delirium resolution, hospital discharge, death, or up to 14 days. The study medication will be given by mouth (PO or per os) or, if needed, via the feeding tube.
Study NCT05713877 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Study drug will be given at 21:00 daily, starting on the day of enrolment until delirium resolution, hospital discharge, death, or up to 14 days. The study medication will be given by mouth (PO or per os) or, if needed, via the feeding tube.
Study NCT06116942 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active rTMS
Description: The Transcranial Magnetic Stimulation will consist of placing a figure-of-eight shape coil of wire over the head of the participants. Then, a brief electric current will pass through the coil, inducing a magnetic field capable of stimulating neurons located beneath the coil. For the active coil, the maximal stimulation intensity is reached beneath the center of the coil.~In the present study, the intermittent theta-burst protocol will be implemented. This protocol is expected to modulate the excitability of the brain, priming it for a stronger activation of the motor-related brain areas engaged during brain-computer interface-based training. The structural MRI of each participant will be used to guide neuronavigation towards ipsilesional motor areas.
Study NCT06116942 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham rTMS
Description: To implement a placebo stimulation, a sham coil will be used to deliver the same stimulation protocol. The sham coil is identical in dimensions and weight to the active coil but produces a diminished magnetic field. For the sham coil, the stimulation intensity is minimal beneath the center of the coil, the same area with the highest intensity during stimulation with an active coil. The structural MRI scan of each participant will be used to guide neuronavigation towards the same area where the active stimulation was applied.
Study NCT05464966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glucose insulin potassium
Description: After induction of anaesthesia,cardiac systolic-diastolic function was first measured by TEE, GIK solution was continuously pumped until the end of the procedure at a dose of 30 mU/kg/h of insulin, 0.12 g/kg/h of glucose and 0.06 mmol/kg/h of potassium chloride
Study NCT05396040 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: LOLLI METHODE
Description: WEEKLY SCREENING WITH POOLED SALIVA PCR TEST
Study NCT06208839 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SBIRT/eIntervention for those with moderate risk drug or alcohol use
Description: The Connections App is available on iOS or Android and will be offered to the patient during the referral process and contains the following functionalities:~* Online view of the referrals made for them e.g. to healthcare provider~* Secure messaging with the referring provider~* Secure messaging with the destination provider(s) to support them to adhere to the referral, and/or the patient can seek assistance with the destination provider,~* Informative multimedia content filtered from a library to fit the patient including testimonial content from peers thus showing the patient that others like them have shared their addiction experience and successfully received treatment and achieved recovery,~* Capture structured feedback from the patient~The patient may access more functionality within the Connections App for those who wish to modify behavior using eTherapy and eRecovery. eRecovery includes ecological momentary assessments (EMA) selected by the provider.
Study NCT06208839 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SBIRT/eIntervention those assessed with high risk.
Description: The Connections App is available on iOS or Android and will be offered to the patient during the referral process and contains the following functionalities:~* Online view of the referrals made for them e.g. to healthcare provider~* Secure messaging with the referring provider~* Secure messaging with the destination provider(s) to support them to adhere to the referral, and/or the patient can seek assistance with the destination provider,~* Informative multimedia content filtered from a library to fit the patient including testimonial content from peers thus showing the patient that others like them have shared their addiction experience and successfully received treatment and achieved recovery,~* Capture structured feedback from the patient~The patient may access more functionality within the Connections App for those who wish to modify behavior using eTherapy and eRecovery. eRecovery includes ecological momentary assessments (EMA) selected by the provider.
Study NCT06208839 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SBIRT/TAU for those with moderate risk drug or alcohol use
Description: Treatment as usual
Study NCT05454852 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: Interviewer-administered survey
Study NCT06208839 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SBIRT/TAU for those assessed with high risk.
Description: Treatment as usual for high risk group
Study NCT05454852 — intervention group
Intervention type: OTHER
Intervention: Focus group
Description: Focus group for selected participants
Study NCT06445491 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control order
Description: Participants will perform an initial baseline of tests, order of 1- 2- 3
Study NCT06445491 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Randomized sequence
Description: the testing order will be randomized for follow up testing.
Study NCT04947384 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: To discern micro-RNA specific for right and left heart induced PH
Description: While undergoing other procedures, the investigators will be collecting a total of three blood samples. The first sample will be obtained on arterial cannulation before the initiation of the intervention, the second sample will be collected upon the end of the procedure prior to leaving the procedure room, and the third sample will be collected on the day of discharge from the hospital.
Study NCT05379283 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine
Description: effect of lidocaine on sweat production during exercise in the heat
Study NCT05379283 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: control
Description: one arm will be pretreated with topical lidocaine, the other arm will not
Study NCT04390503 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Convalescent Plasma (anti-SARS-CoV-2 plasma)
Description: Convalescent Plasma that contains antibody titers against SARS-CoV-2.
Study NCT04390503 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Control (albumin 5%)
Description: Albumin (Human) 5% is a sterile aqueous solution for intravenous use containing the albumin component human plasma.
Study NCT05807074 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid
Description: Applied intraoperatively
Study NCT05807074 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline
Description: Applied intraoperatively
Study NCT04661280 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil
Description: Donepezil 5 mg per day during one month, then 10 mg per day during 5 months.
Study NCT04860973 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Weighted blankets
Description: Weighted blankets given to patient for 7 days/nights
Study NCT05567653 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus helveticus Rosell-52 and Bifidobacterium longum Rosell-175 (Sanprobi Stress)
Description: 3-month, multi-strain probiotic supplementation (one a day, 3 x 10⁹ CFU)
Study NCT05567653 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Starch (placebo)
Description: 3-month placebo
Study NCT06700915 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Diaberine
Description: Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.
Study NCT06700915 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Capsule
Description: Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.
Study NCT06698887 — intervention group
Intervention type: DRUG
Intervention: Idecabtagene vicleucel
Description: As per CA089-1043 study protocol
Study NCT04632069 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: N acetyl cysteine + vagus nerve stimulation
Description: NAC x 14 days, taVNS x 10 days
Study NCT06724510 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HIFU treatment with ULTRAFOMER MPT
Description: The high-intensity focused ultrasound (HIFU) treatment, which is the primary intervention being evaluated for efficacy and safety in eyebrow lifting.
Study NCT06730373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disitamab Vedotin
Description: 2.5 mg/kg IV every 3 weeks
Study NCT04770220 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental: ALZ-801
Description: ALZ-801 tablet 265 mg BID
Study NCT06730373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 200 mg IV every 3 weeks
Study NCT06730373 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sintilimab
Description: 200 mg IV every 3 weeks
Study NCT06730373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-1
Description: 40-60 mg BID for 14 days, every 3 weeks
Study NCT06730373 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trastuzumab
Description: First load dose is 8.0mg/kg , then 6.0 mg/kg IV every 3 weeks
Study NCT06730373 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin
Description: 130 mg/m2 Q3W
Study NCT06730373 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Description: 1000 mg/m² Q3W
Study NCT06730373 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-FU
Description: 800 mg/m²
Study NCT06730373 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: 80 mg/m²
Study NCT06724991 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lower Dose Therapy
Description: The group receiving the lower-dose therapy consists of 5 units of Actrapid (insulin) with 25cc of Dextrose 50%. This intervention is the focus of the clinical trial and is being investigated to determine if it achieves a comparable reduction in potassium levels with fewer potential complications. The aim is to establish it as a non-inferior alternative to conventional-dose therapy in the management of mild and moderate hyperkalemia.
Study NCT04770220 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator: Placebo
Description: Placebo tablet BID
Study NCT06448507 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: INJEX [Needle less anesthesia]
Description: already described
Study NCT06448507 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Syringe Needle [ Traditional technique]
Description: described
Study NCT05997069 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Posterior-anterior vertebral mobilizations followed by Prone press-up exercise
Description: Posterior-anterior vertebral mobilizations of the lumbar spine are achieved by applying a force on to a spinous process in a posteroanterior direction (Back to front).~Prone press-up exercise is started in the prone position (lying on stomach) on a flat surface. Participant keeps hands underneath the shoulders then press up his or her upper body while trying to keep the hips on the floor.
Study NCT05303142 — intervention group
Intervention type: OTHER
Intervention: Heat Tolerance Assessment
Description: 60-90 minutes exercise in hot (34 °C; 45% R.H.) conditions at 60%VO2max